论文部分内容阅读
目的观察小儿肺炎采用布地奈德雾化吸入治疗的疗效。方法 226例小儿肺炎患儿随机分为治疗组(126例)与对照组(100例),对照组进行常规治疗,治疗组患儿采用布地奈德雾化吸入治疗,比较两组患儿的临床治疗效果。结果治疗组患儿与对照组患儿相比,治疗组总有效率94.44%明显高于对照组的71.00%,差异具有统计学意义(P<0.01);两组患儿不良反应发生情况比较,差异无统计学意义(P>0.05)。结论布地奈德雾化吸入配合常规治疗能够有效提高小儿肺炎的治疗效果,且具有较高的安全性,值得临床上进一步推广应用。
Objective To observe the efficacy of budesonide inhalation therapy in children with pneumonia. Methods A total of 226 children with pneumonia were randomly divided into treatment group (n = 126) and control group (n = 100). The control group was treated routinely. The treatment group received budesonide inhalation therapy. treatment effect. Results Compared with children in the control group, the total effective rate in the treatment group was significantly higher than that in the control group (94.44% vs 71.00%, P <0.01). The incidence of adverse reactions in both groups was significantly higher than that in the control group The difference was not statistically significant (P> 0.05). Conclusion Budesonide inhalation combined with conventional treatment can effectively improve the therapeutic effect of pediatric pneumonia, and has high safety, it is worth to further promote the clinical application.